Stocks soared for medical device maker Abbott Laboratories after it announced it received emergency approval from the Food and Drug Administration on March 18 to distribute its unique test to detect the COVID-19 virus.
Stocks soared for medical device maker Abbott Laboratories after it announced it received emergency approval from the Food and Drug Administration on March 18 to distribute its unique test to detect the COVID-19 virus.